More views on screening mammography

In ‘Stop ‘Selling’ Cancer Screening, Says Critic -Publicize Harms and Benefits’ (Medscape Medical News – Oncology) – Nick Mulcahy discusses a commentary ‘Uninformed compliance or informed choice? A needed shift in our approach to cancer screening’, by Michael Stefanek, PhD, Associate Vice President of Collaborative Research in the office of the vice president at Indiana University in Bloomington, published online 21 November in the Journal of the National Cancer Institute, which concludes rather than persuading the public about screening, ‘It seems that it would be much more productive to devote such energy to educating screening candidates about the harms and benefits of screening and to engaging in shared decision making.’

But he points out that ‘both breast and prostate cancer screening suffer from a “similar ambiguity of evidence,”. However, guidelines “have typically recommended that men make informed decisions about prostate cancer screening,” whereas women have been summoned to breast cancer screening.’

Mammography wars, editorial, Fiona Godlee

and rapid responses, particularly this one from Miriam Pryke

and it’s easy to understand why the screening programme has been allowed to roll on and on despite mounting research evidence illustrating the level of harms.

About bmitzi

Medical writer, author, artist. Cancer campaigner. Aiming always to improve health services and bring compassion into health care.
This entry was posted in Uncategorized and tagged , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s